Stryker (SYK) Return on Capital Employed (2009 - 2026)
Stryker (SYK) reported Return on Capital Employed of 12.24% for Q1 2026, up 252.0% year-over-year from 3.48% in Q1 2025, and down 0.72% on a QoQ basis from 12.33% in Q4 2025.
Stryker (SYK) has 18 years of Return on Capital Employed data on file, last reported at 12.24% in Q1 2026.
- Quarterly Return on Capital Employed rose 252.0% year-over-year to 12.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.24% (up 252.0% YoY) and the FY2025 annual result came in at 13.0%, up 209.0% from the prior year.
- Return on Capital Employed retreated to 12.24% in Q1 2026 per SYK's latest filing, from 12.33% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 13.02% in Q2 2024 and bottomed at 8.24% in Q2 2022.
- The 5-year median for Return on Capital Employed is 10.31% (2024), against an average of 10.69%.
- The widest annual swing landed in 2023, when Return on Capital Employed jumped 309 bps; it then plunged 372 bps in 2025.
- Tracing SYK's Return on Capital Employed over 5 years: stood at 9.43% in 2022, then surged by 33 bps to 12.52% in 2023, then slipped by 18 bps to 10.31% in 2024, then rose by 20 bps to 12.33% in 2025, then slipped by 1 bps to 12.24% in 2026.
- Per Business Quant, the three latest SYK Return on Capital Employed figures stand at 12.24% (Q1 2026), 12.33% (Q4 2025), and 9.33% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 5.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.24% |
| Dec 31, 2025 | 12.33% |
| Sep 30, 2025 | 9.33% |
| Jun 30, 2025 | 9.30% |
| Mar 31, 2025 | 9.72% |
| Dec 31, 2024 | 10.31% |
| Sep 30, 2024 | 12.91% |
| Jun 30, 2024 | 13.02% |
| Mar 31, 2024 | 12.61% |
| Dec 31, 2023 | 12.52% |
| Sep 30, 2023 | 11.38% |
| Jun 30, 2023 | 10.88% |
| Mar 31, 2023 | 10.10% |
| Dec 31, 2022 | 9.43% |
| Sep 30, 2022 | 9.05% |
| Jun 30, 2022 | 8.24% |
| Mar 31, 2022 | 8.30% |
| Dec 31, 2021 | 8.66% |
| Sep 30, 2021 | 8.53% |
| Jun 30, 2021 | 9.54% |
| Mar 31, 2021 | 6.84% |
| Dec 31, 2020 | 7.86% |
| Sep 30, 2020 | 8.89% |
| Jun 30, 2020 | 8.39% |
| Mar 31, 2020 | 11.00% |
| Dec 31, 2019 | 11.30% |
| Sep 30, 2019 | 10.92% |
| Jun 30, 2019 | 10.88% |
| Mar 31, 2019 | 10.82% |
| Dec 31, 2018 | 12.78% |
| Sep 30, 2018 | 14.44% |
| Jun 30, 2018 | 14.05% |
| Mar 31, 2018 | 13.43% |
| Dec 31, 2017 | 12.51% |
| Sep 30, 2017 | 12.43% |
| Jun 30, 2017 | 12.76% |
| Mar 31, 2017 | 12.34% |
| Dec 31, 2016 | 12.67% |
| Sep 30, 2016 | 12.43% |
| Jun 30, 2016 | 12.40% |
| Mar 31, 2016 | 13.37% |
| Dec 31, 2015 | 14.81% |
| Sep 30, 2015 | 13.12% |
| Jun 30, 2015 | 13.51% |
| Mar 31, 2015 | 11.50% |
| Dec 31, 2014 | 9.64% |
| Sep 30, 2014 | 9.18% |
| Jun 30, 2014 | 6.99% |
| Mar 31, 2014 | 8.19% |
| Dec 31, 2013 | 10.06% |
| Sep 30, 2013 | 9.72% |
| Jun 30, 2013 | 12.20% |
| Mar 31, 2013 | 13.94% |
| Dec 31, 2012 | 15.66% |
| Sep 30, 2012 | 16.35% |
| Jun 30, 2012 | 16.40% |
| Mar 31, 2012 | 16.17% |
| Dec 31, 2011 | 16.41% |
| Sep 30, 2011 | 16.09% |
| Jun 30, 2011 | 17.14% |
| Mar 31, 2011 | 18.47% |
| Dec 31, 2010 | 19.23% |
| Sep 30, 2010 | 20.86% |
| Jun 30, 2010 | 19.58% |
| Mar 31, 2010 | 20.31% |
| Dec 31, 2009 | 21.76% |
| Sep 30, 2009 | 20.74% |